| 000 | 01757 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513121659.0 | ||
| 264 | 0 | _c19970721 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a1098-4275 | ||
| 024 | 7 |
_a10.1542/peds.100.1.24 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavis, J M | |
| 245 | 0 | 0 |
_aSafety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. _h[electronic resource] |
| 260 |
_bPediatrics _cJul 1997 |
||
| 300 |
_a24-30 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntibodies _xanalysis |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBronchopulmonary Dysplasia _xprevention & control |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aIntubation, Intratracheal |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome, Newborn _xblood |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aRosenfeld, W N | |
| 700 | 1 | _aRichter, S E | |
| 700 | 1 | _aParad, M R | |
| 700 | 1 | _aGewolb, I H | |
| 700 | 1 | _aSpitzer, A R | |
| 700 | 1 | _aCarlo, W A | |
| 700 | 1 | _aCouser, R J | |
| 700 | 1 | _aPrice, A | |
| 700 | 1 | _aFlaster, E | |
| 700 | 1 | _aKassem, N | |
| 700 | 1 | _aEdwards, L | |
| 700 | 1 | _aTierney, J | |
| 700 | 1 | _aHorowitz, S | |
| 773 | 0 |
_tPediatrics _gvol. 100 _gno. 1 _gp. 24-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1542/peds.100.1.24 _zAvailable from publisher's website |
| 999 |
_c9180871 _d9180871 |
||